Please Wait
Applying Filters...
menu
    • menu
    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Pibrentasvir

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 43,655Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    11/10/2024 AbbVie Inc
    U.S.A
    		 AbbVie Korea Inc. Su325-8-ND Pibrentasvir 2017-12-15 [Raw material pharmaceutical manufacturing] Abbvie Ireland NL BV@[Intermediate 1-5 manufacturing] Procos SpA Japan Manorhamilton Road, Sligo, Ireland@Via Matteotti, 249 28062 Cameri(NO), Italy
    28/09/2024 ACS DOBFAR SPA
    Italy
    		 AbbVie Korea Inc. Su325-13-ND Pibrentasvir 2020-10-08 AbbVie Srl Italy SR 148 Pontina km 52, Snc - Campoverde di Aprilia, 04011 Aprilia (LT), Italy